Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders

Cecilia Nakid-Cordero
Marine Baron
Amélie Guihot
  • Fonction : Auteur

Résumé

Post-transplant lymphoproliferative disorders (PTLDs) are life-threatening complications arising after solid organ or hematopoietic stem cell transplantations. Although the majority of these lymphoproliferations are of B cell origin, and are frequently associated with primary Epstein–Barr virus (EBV) infection or reactivation in the post-transplant period, rare cases of T cell and natural killer (NK) cell-originated PTLDs have also been described. A general assumption is that PTLDs result from the impairment of anti-viral and anti-tumoral immunosurveillance due to the long-term use of immunosuppressants in transplant recipients. T cell impairment is known to play a critical role in the immune-pathogenesis of post-transplant EBV-linked complications, while the role of NK cells has been less investigated, and is probably different between EBV-positive and EBV-negative PTLDs. As a part of the innate immune response, NK cells are critical for protecting hosts during the early response to virus-induced tumors. The complexity of their function is modulated by a myriad of activating and inhibitory receptors expressed on cell surfaces. This review outlines our current understanding of NK cells in the pathogenesis of PTLD, and discusses their potential implications for current PTLD therapies and novel NK cell-based therapies for the containment of these disorders.

Dates et versions

hal-03382747 , version 1 (18-10-2021)

Identifiants

Citer

Cecilia Nakid-Cordero, Marine Baron, Amélie Guihot, Vincent Vieillard. Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders. Cancers, 2021, 13 (8), pp.1836. ⟨10.3390/cancers13081836⟩. ⟨hal-03382747⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More